Statistics in medical journals: some recent trends.
暂无分享,去创建一个
[1] D G Altman,et al. Confidence intervals for the number needed to treat , 1998, BMJ.
[2] Moses Le,et al. MEASURING EFFECTS WITHOUT RANDOMIZED TRIALS ? OPTIONS, PROBLEMS, CHALLENGES , 1995 .
[3] G Lewis,et al. Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology. , 1997, Journal of epidemiology and community health.
[4] Lisa A. Weissfeld,et al. A study of the effect of dichotomizing ordinal data upon modeling , 1998 .
[5] D P Byar,et al. Using observational data from registries to compare treatments: the fallacy of omnimetrics. , 1984, Statistics in medicine.
[6] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[7] J. Simpson,et al. Accounting for cluster randomization: a review of primary prevention trials, 1990 through 1993. , 1995, American journal of public health.
[8] David R. Jones,et al. Systematic reviews of trials and other studies. , 1998, Health technology assessment.
[9] W. Sauerbrei,et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.
[10] D G Altman,et al. Statistics in medical journals. , 1982, Statistics in medicine.
[11] M. Kanter,et al. Accuracy of statistical methods in TRANSFUSION: a review of articles from July/August 1992 through June 1993 , 1994, Transfusion.
[12] R. Aster,et al. Statistics in articles published in TRANSFUSION , 1994, Transfusion.
[13] G. Smith,et al. Meta-analysis Spurious precision? Meta-analysis of observational studies , 1998, BMJ.
[14] David R. Jones,et al. An introduction to bayesian methods in health technology assessment , 1999, BMJ.
[15] Sponsored trials do not necessarily give more-favourable results , 1999, BMJ.
[16] D. Bruns,et al. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. , 2000, Clinical chemistry.
[17] Beyond conflict of interest. Biomedical journals need a concerted response against influence of tobacco industry. , 1999 .
[18] J J Deeks,et al. Systematic reviews of published evidence: miracles or minefields? , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] T. Perneger. What's wrong with Bonferroni adjustments , 1998, BMJ.
[20] D A Katerndahl,et al. Variability in meta-analytic results concerning the value of cholesterol reduction in coronary heart disease: a meta-meta-analysis. , 1999, American journal of epidemiology.
[21] B. H. Layne,et al. Low power, type II errors, and other statistical problems in recent cardiovascular research. , 1997, The American journal of physiology.
[22] S. Hollis,et al. What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.
[23] A. Carr,et al. Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. , 1998, Health technology assessment.
[24] P. Bossuyt,et al. Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.
[25] D Wartenberg,et al. Defining exposure in case-control studies: a new approach. , 1991, American journal of epidemiology.
[26] S J White,et al. Statistical Errors in Papers in the British Journal of Psychiatry , 1979, British Journal of Psychiatry.
[27] K J Rothman,et al. Writing for Epidemiology , 1998, Epidemiology.
[28] D. Altman. Suboptimal analysis using 'optimal' cutpoints. , 1998, British Journal of Cancer.
[29] D Moher,et al. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.
[30] M. Egger,et al. The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.
[31] A D Oxman,et al. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials , 1998, BMJ.
[32] E. Skovlund,et al. A critical review of papers from clinical cancer research. , 1998, Acta oncologica.
[33] Norman E. Breslow,et al. Biostatistics and Bayes , 1990 .
[34] Jacob Cohen. The Cost of Dichotomization , 1983 .
[35] S. Goodman,et al. Multiple comparisons, explained. , 1998, American journal of epidemiology.
[36] D L Sackett,et al. An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.
[37] D. Cook,et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.
[38] P. Gøtzsche. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.
[39] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[40] D G Altman,et al. Statistics notes: Absence of evidence is not evidence of absence , 1995 .
[41] D G Altman,et al. Statistics Notes: Interaction 2: compare effect sizes not P values , 1996, BMJ.
[42] L. Smeeth,et al. Numbers needed to treat derived from meta-analyses—sometimes informative, usually misleading , 1999, BMJ.
[43] J M Bland,et al. Trials which randomize practices II: sample size. , 1998, Family practice.
[44] D. Sackett,et al. 70 Choosing an appropriate dichotomous effect measure for meta-analysis: Empirical evidence of the appropriateness of the odds ratio and relative risk , 1997 .
[45] K J Rothman,et al. No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.
[46] G. E. Welch,et al. Review of statistics usage in the American Journal of Obstetrics and Gynecology. , 1996, American journal of obstetrics and gynecology.
[47] L A Moyé,et al. P-value interpretation and alpha allocation in clinical trials. , 1998, Annals of epidemiology.
[48] D G Altman,et al. The scandal of poor medical research , 1994, BMJ.
[49] Richard J Lilford,et al. Ethical issues in the design and conduct of cluster randomised controlled trials , 1999, BMJ.
[50] P A Lachenbruch,et al. Some Misuses of Discriminant Analysis , 1977, Methods of Information in Medicine.
[51] S Greenland,et al. Random-effects meta-analyses are not always conservative. , 1999, American journal of epidemiology.
[52] J M Bland,et al. Trials which randomize practices I: how should they be analysed? , 1998, Family practice.
[53] C. Adams,et al. Content and quality of 2000 controlled trials in schizophrenia over 50 years , 1998, BMJ.
[54] N. Black. Why we need observational studies to evaluate the effectiveness of health care , 1996, BMJ.
[55] G. Andrews,et al. Meta-analysis of the effects of stuttering treatment. , 1980, The Journal of speech and hearing disorders.
[56] Jonathan J. Deeks,et al. Down with odds ratios! , 1996, Evidence Based Medicine.
[57] N. Black,et al. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.
[58] L. Bouter,et al. Methodological Quality of Randomized Clinical Trials on Treatment Efficcact in Low Back Pain , 1995, Spine.
[59] S. Mcguigan. The use of Statistics in the British Journal of Psychiatry , 1995, British Journal of Psychiatry.
[60] D A Savitz,et al. Statistical significance testing in the American Journal of Epidemiology, 1970-1990. , 1994, American journal of epidemiology.
[61] Sj Senn,et al. Odds ratios revisited , 1998 .
[62] K. Ottenbacher. Quantitative evaluation of multiplicity in epidemiology and public health research. , 1998, American journal of epidemiology.
[63] S Greenland,et al. Can meta-analysis be salvaged? , 1994, American journal of epidemiology.
[64] J. Vandenbroucke,et al. Observational research and evidence-based medicine: What should we teach young physicians? , 1998, Journal of clinical epidemiology.
[65] D G Altman,et al. Statistics notes: Interaction 3: How to examine heterogeneity , 1996 .
[66] Allan Donner,et al. Some aspects of the design and analysis of cluster randomization trials , 2002 .
[67] D Curran-Everett,et al. Fundamental concepts in statistics: elucidation and illustration. , 1998, Journal of applied physiology.
[68] M. Bracken,et al. Clinically useful measures of effect in binary analyses of randomized trials. , 1994, Journal of clinical epidemiology.
[69] L E Moses,et al. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. , 1993, Statistics in medicine.
[70] D. Potvin,et al. Multistage designs for phase II clinical trials: statistical issues in cancer research. , 1996, British Journal of Cancer.
[71] J E Cottrell,et al. Absence of evidence is not evidence of absence. , 1983, Anesthesiology.
[72] J. Vandenbroucke,et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis , 1992, The Lancet.
[73] D. Spiegelhalter,et al. Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. , 1998, BMJ.
[74] U Grouven,et al. Logistic regression models used in medical research are poorly presented , 1996, BMJ.
[75] S. Greenland. Quality Scores Are Useless and Potentially Misleading: Reply to “Re: A Critical Look at Some Popular Analytic Methods” , 1994 .
[76] C Bain,et al. Choosing between randomised and non-randomised studies: a systematic review. , 1998, Health technology assessment.
[77] J. Hall,et al. Methodologic standards in surgical trials. , 1996, Surgery.
[78] S. Greenland. Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis , 1995, Epidemiology.
[79] M. Stokes,et al. Reliability of assessment tools in rehabilitation: an illustration of appropriate statistical analyses , 1998, Clinical rehabilitation.
[80] W B Jonas,et al. Impact of study quality on outcome in placebo-controlled trials of homeopathy. , 1999, Journal of clinical epidemiology.
[81] D. Hand,et al. Improving the Quality of Statistics in Psychiatric Research , 1995, British Journal of Psychiatry.
[82] G. Glass. Primary, Secondary, and Meta-Analysis of Research1 , 1976 .
[83] Valérie Buthion,et al. ColoNav: patient navigation for colorectal cancer screening in deprived areas – Study protocol , 1999, BMC Cancer.
[84] F. Davidoff. In the teeth of the evidence: the curious case of evidence-based medicine. , 1999, The Mount Sinai journal of medicine, New York.
[85] D G Altman,et al. Statistics in medical journals: developments in the 1980s. , 1991, Statistics in medicine.
[86] N. Cozens. Should we have confidence in radiology papers? , 1994, Clinical radiology.
[87] P Glasziou,et al. Meta-analytic methods for diagnostic test accuracy. , 1995, Journal of clinical epidemiology.
[88] H Brenner,et al. Controlling for Continuous Confounders in Epidemiologic Research , 1997, Epidemiology.
[89] K J Rothman,et al. A show of confidence. , 1978, The New England journal of medicine.
[90] A R Jadad,et al. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. , 1995, Controlled clinical trials.
[91] W. Vach,et al. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. , 2000, Statistics in medicine.
[92] D G Altman,et al. Transfer of technology from statistical journals to the biomedical literature. Past trends and future predictions. , 1994, JAMA.
[93] C. Rembold. Number needed to screen: development of a statistic for disease screening , 1998, BMJ.
[94] A Donner,et al. A methodological review of non-therapeutic intervention trials employing cluster randomization, 1979-1989. , 1990, International journal of epidemiology.
[95] L E Moses,et al. Estimating Diagnostic Accuracy from Multiple Conflicting Reports , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.